ID

24725

Descrição

Study of Concurrent Chemotherapy and Radiotherapy for Stage II Nasopharyngeal Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00817258

Link

https://clinicaltrials.gov/show/NCT00817258

Palavras-chave

  1. 15/08/2017 15/08/2017 -
Transferido a

15 de agosto de 2017

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Nasopharyngeal Carcinoma NCT00817258

Eligibility Nasopharyngeal Carcinoma NCT00817258

Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically proven differentiated non-keratinizing carcinoma, and undifferentiated carcinoma of the nasopharynx.
Descrição

Nasopharyngeal Differentiated Nonkeratinizing Carcinoma | Undifferentiated carcinoma of nasopharynx

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1709153
UMLS CUI [2]
C0279748
stage ii disease (t1-2; n1; m0)
Descrição

Disease TNM clinical staging

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C3258246
kps >70
Descrição

Karnofsky Performance Status

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0206065
age between 18-70
Descrição

Age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
patients should have adequate bone marrow function defined as an absolute peripheral granulocyte count (agc) of > 2000 cells/mm3, platelet count of > 100,000 cells/mm3 (pre treatment without intervention). bilirubin < 1.5 mg/dl, ast or alt<2 x upper normal, serum creatinine<1.5mg/dl, creatinine clearance >50ml/min.
Descrição

Bone Marrow function | Absolute neutrophil count | Platelet Count measurement pre treatment | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Creatinine measurement, serum | Creatinine clearance measurement

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0948762
UMLS CUI [3,1]
C0032181
UMLS CUI [3,2]
C2709094
UMLS CUI [4]
C1278039
UMLS CUI [5]
C0201899
UMLS CUI [6]
C0201836
UMLS CUI [7]
C0201976
UMLS CUI [8]
C0373595
no prior radiation treatment to the head and neck or any prior chemotherapy
Descrição

Radiotherapy to head and neck Absent | Chemotherapy Absent

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C3888854
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C0332197
patients with no prior malignancy (not include basal cell carcinoma of skin)
Descrição

Malignant Neoplasms Absent | Exception Basal cell carcinoma

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0007117
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
evidence of metastases (below the clavicle or distant) by clinical or radiographic examinations.
Descrição

Neoplasm Metastasis Below Clavicle Physical Examination | Distant metastasis Physical Examination | Neoplasm Metastasis Below Clavicle Radiography | Distant metastasis Radiography

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C0542339
UMLS CUI [1,3]
C0008913
UMLS CUI [1,4]
C0031809
UMLS CUI [2,1]
C1269798
UMLS CUI [2,2]
C0031809
UMLS CUI [3,1]
C0027627
UMLS CUI [3,2]
C0542339
UMLS CUI [3,3]
C0008913
UMLS CUI [3,4]
C0034571
UMLS CUI [4,1]
C1269798
UMLS CUI [4,2]
C0034571
prior radiotherapy to the head and neck region for any reason.
Descrição

Radiotherapy to head and neck

Tipo de dados

boolean

Alias
UMLS CUI [1]
C3888854
initial surgical treatment excluding diagnostic biopsy of the primary site or neck disease.
Descrição

Operative Surgical Procedure Initial Disorder of neck Primary site | Exception Biopsy

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0543467
UMLS CUI [1,2]
C0205265
UMLS CUI [1,3]
C0558385
UMLS CUI [1,4]
C0449695
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0005558
patients with previous or simultaneous primaries, excluding basal cell carcinoma or squamous cell carcinoma of skin.
Descrição

Primary tumor | Exception Basal cell carcinoma | Exception Squamous cell carcinoma of skin

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0677930
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0007117
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0553723
pregnant women.
Descrição

Pregnancy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032961

Similar models

Eligibility Nasopharyngeal Carcinoma NCT00817258

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Nasopharyngeal Differentiated Nonkeratinizing Carcinoma | Undifferentiated carcinoma of nasopharynx
Item
histologically proven differentiated non-keratinizing carcinoma, and undifferentiated carcinoma of the nasopharynx.
boolean
C1709153 (UMLS CUI [1])
C0279748 (UMLS CUI [2])
Disease TNM clinical staging
Item
stage ii disease (t1-2; n1; m0)
boolean
C0012634 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Karnofsky Performance Status
Item
kps >70
boolean
C0206065 (UMLS CUI [1])
Age
Item
age between 18-70
boolean
C0001779 (UMLS CUI [1])
Bone Marrow function | Absolute neutrophil count | Platelet Count measurement pre treatment | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Creatinine measurement, serum | Creatinine clearance measurement
Item
patients should have adequate bone marrow function defined as an absolute peripheral granulocyte count (agc) of > 2000 cells/mm3, platelet count of > 100,000 cells/mm3 (pre treatment without intervention). bilirubin < 1.5 mg/dl, ast or alt<2 x upper normal, serum creatinine<1.5mg/dl, creatinine clearance >50ml/min.
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0948762 (UMLS CUI [2])
C0032181 (UMLS CUI [3,1])
C2709094 (UMLS CUI [3,2])
C1278039 (UMLS CUI [4])
C0201899 (UMLS CUI [5])
C0201836 (UMLS CUI [6])
C0201976 (UMLS CUI [7])
C0373595 (UMLS CUI [8])
Radiotherapy to head and neck Absent | Chemotherapy Absent
Item
no prior radiation treatment to the head and neck or any prior chemotherapy
boolean
C3888854 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Malignant Neoplasms Absent | Exception Basal cell carcinoma
Item
patients with no prior malignancy (not include basal cell carcinoma of skin)
boolean
C0006826 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Neoplasm Metastasis Below Clavicle Physical Examination | Distant metastasis Physical Examination | Neoplasm Metastasis Below Clavicle Radiography | Distant metastasis Radiography
Item
evidence of metastases (below the clavicle or distant) by clinical or radiographic examinations.
boolean
C0027627 (UMLS CUI [1,1])
C0542339 (UMLS CUI [1,2])
C0008913 (UMLS CUI [1,3])
C0031809 (UMLS CUI [1,4])
C1269798 (UMLS CUI [2,1])
C0031809 (UMLS CUI [2,2])
C0027627 (UMLS CUI [3,1])
C0542339 (UMLS CUI [3,2])
C0008913 (UMLS CUI [3,3])
C0034571 (UMLS CUI [3,4])
C1269798 (UMLS CUI [4,1])
C0034571 (UMLS CUI [4,2])
Radiotherapy to head and neck
Item
prior radiotherapy to the head and neck region for any reason.
boolean
C3888854 (UMLS CUI [1])
Operative Surgical Procedure Initial Disorder of neck Primary site | Exception Biopsy
Item
initial surgical treatment excluding diagnostic biopsy of the primary site or neck disease.
boolean
C0543467 (UMLS CUI [1,1])
C0205265 (UMLS CUI [1,2])
C0558385 (UMLS CUI [1,3])
C0449695 (UMLS CUI [1,4])
C1705847 (UMLS CUI [2,1])
C0005558 (UMLS CUI [2,2])
Primary tumor | Exception Basal cell carcinoma | Exception Squamous cell carcinoma of skin
Item
patients with previous or simultaneous primaries, excluding basal cell carcinoma or squamous cell carcinoma of skin.
boolean
C0677930 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0553723 (UMLS CUI [3,2])
Pregnancy
Item
pregnant women.
boolean
C0032961 (UMLS CUI [1])

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial